CHICAGO — On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease. “This approval is a victory for people living with Alzheimer’s and their families,” said Harry Johns, Alzheimer’s Association president and chief executive officer. “This is the first FDA-approved drug that delays
CHICAGO — For the second consecutive November, the Alzheimer’s Association and CVS Health will join together for an in-store fundraising campaign aimed at fighting Alzheimer’s disease – a disease impacting more than 5 million Americans and 16 million caregivers across the country. The campaign is part of a three-year, $10 million commitment from CVS Health to the Alzheimer’s
CHICAGO — The Alzheimer’s Association and CVS Health announced Monday a three-year corporate partnership aimed at fighting Alzheimer’s disease – a disease impacting more than 5 million Americans and 16 million caregivers across the country. The partnership is launching with an in-store fundraising campaign that will provide $10 million to support Alzheimer’s Association programs, including
WOONSOCKET, R.I. — The CVS Health Foundation is making a $550,000 grant to the Alzheimer’s Association to boost its support for a new program to enhance disease diagnosis and assessment with clinicians and to educate them about care and support programs to help families. CVS said the grant, which is being shared with six local
